EGFRvIII Antibody

Known as: Anti-EGFRvIII, Anti-EGFRvIII Antibody 
An antibody directed against the epidermal growth factor receptor class III variant (EGFRvIII).
National Institutes of Health

Topic mentions per year

Topic mentions per year

2003-2017
012320032017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Epidermal growth factor receptor variant III (EGFRvIII) is the most common variant of the EGF receptor in many human tumors. This… (More)
  • table 1
  • figure 2
  • figure 1
  • figure 4
  • figure 3
Is this relevant?
2017
2017
Therapeutics based on small interfering RNAs (siRNAs) offer a great potential to treat so far incurable diseases or metastatic… (More)
Is this relevant?
Review
2017
Review
2017
Glioblastoma (GBM) is one of the most devastating brain tumors with poor prognosis and high mortality. Although radical surgical… (More)
Is this relevant?
Review
2017
Review
2017
In epithelial tumors, the epidermal growth factor receptor (EGFR) controls key signaling pathways responsible for growth… (More)
  • table 1
Is this relevant?
2013
2013
BACKGROUND Epidermal growth factor receptor (EGFR) gene alterations play important roles in pathogenesis of glioblastoma… (More)
  • figure 1
  • figure 2
  • table I
Is this relevant?
2013
2013
BACKGROUND Expression of miR-17-92 enhances T-cell survival and interferon (IFN)-γ production. We previously reported that miR-17… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2006
2006
INTRODUCTION MR1-1 is a single-chain Fv (scFv) fragment that binds with high affinity to epidermal growth factor receptor variant… (More)
Is this relevant?
2003
2003
EGFRvIII is a tumor specific, ligand-independent, constitutively active variant of the epidermal growth factor receptor. Its… (More)
Is this relevant?